I think the problem is that the
MEDDEV 2.7/1 rev 4 describes the whole
process of performing the clinical evaluation, in (maybe too much) detail.
The
MDR (Annex XIV) describes the minimal
contents that have to be the results of stage 0 (defining then scope), also in much detail. It also contains the requirement of having a CEP and the new
clinical development plan.
So, you have to combine the requirements of both documents, adjusted to your specific device. Since both the guidance and the regulation are rather detailed, it should be no rocket science to create an own template. The hard part, in my opinion, is to define the specific contents required by the MDR.
If you browse the book by Ecker et. al. (ISBN 9783751937665), which I do not recommend specifically, you get a better idea of the minds of some of the persons behind these two documents.